100 related articles for article (PubMed ID: 30226582)
1. ARHGEF4 predicts poor prognosis and promotes cell invasion by influencing ERK1/2 and GSK-3α/β signaling in pancreatic cancer.
Taniuchi K; Furihata M; Naganuma S; Saibara T
Int J Oncol; 2018 Nov; 53(5):2224-2240. PubMed ID: 30226582
[TBL] [Abstract][Full Text] [Related]
2. Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells.
Tsuboi M; Taniuchi K; Furihata M; Naganuma S; Kimura M; Watanabe R; Shimizu T; Saito M; Dabanaka K; Hanazaki K; Saibara T
Pancreatology; 2016; 16(5):905-16. PubMed ID: 27453460
[TBL] [Abstract][Full Text] [Related]
3. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.
Tanouchi A; Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Kimura M; Watanabe R; Kohsaki T; Shimizu T; Saito M; Hanazaki K; Saibara T
J Exp Clin Cancer Res; 2016 Dec; 35(1):190. PubMed ID: 27919290
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells.
Tsuboi M; Taniuchi K; Shimizu T; Saito M; Saibara T
J Biol Chem; 2017 Oct; 292(43):17681-17702. PubMed ID: 28912272
[No Abstract] [Full Text] [Related]
5. KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells.
Taniuchi K; Furihata M; Saibara T
Neoplasia; 2014 Dec; 16(12):1082-93. PubMed ID: 25499221
[TBL] [Abstract][Full Text] [Related]
6. CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.
Yan Z; Ohuchida K; Zheng B; Okumura T; Takesue S; Nakayama H; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M
J Cancer Res Clin Oncol; 2019 May; 145(5):1147-1164. PubMed ID: 30770989
[TBL] [Abstract][Full Text] [Related]
7. ShRNA silencing glycogen synthase kinase-3 beta inhibits tumor growth and angiogenesis in pancreatic cancer.
Zhou W; Wang L; Gou SM; Wang TL; Zhang M; Liu T; Wang CY
Cancer Lett; 2012 Mar; 316(2):178-86. PubMed ID: 22100174
[TBL] [Abstract][Full Text] [Related]
8. WAVE2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness via binding to ACTN4.
Taniuchi K; Furihata M; Naganuma S; Saibara T
Cancer Med; 2018 Nov; 7(11):5733-5751. PubMed ID: 30353690
[TBL] [Abstract][Full Text] [Related]
9. Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin.
Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Hanazaki K; Saibara T
Cancer Sci; 2016 Oct; 107(10):1430-1442. PubMed ID: 27461278
[TBL] [Abstract][Full Text] [Related]
10. RUVBL1 directly binds actin filaments and induces formation of cell protrusions to promote pancreatic cancer cell invasion.
Taniuchi K; Furihata M; Iwasaki S; Tanaka K; Shimizu T; Saito M; Saibara T
Int J Oncol; 2014 Jun; 44(6):1945-54. PubMed ID: 24728183
[TBL] [Abstract][Full Text] [Related]
11. ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells.
Fukushima H; Yasumoto M; Ogasawara S; Akiba J; Kitasato Y; Nakayama M; Naito Y; Ishida Y; Okabe Y; Yasunaga M; Horiuchi H; Sakamoto E; Itadani H; Mizuarai S; Oie S; Yano H
Mol Cancer; 2016 May; 15(1):32. PubMed ID: 27145964
[TBL] [Abstract][Full Text] [Related]
12. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.
Xu X; Zhao Z; Guo S; Li J; Liu S; You Y; Ni B; Wang H; Bie P
Cancer Lett; 2017 Jul; 397():12-22. PubMed ID: 28315433
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase.
Wang Q; Zhou Y; Wang X; Evers BM
Oncogene; 2006 Jan; 25(1):43-50. PubMed ID: 16278684
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic role of TYRO3 receptor tyrosine kinase in the progression of pancreatic cancer.
Morimoto M; Horikoshi Y; Nakaso K; Kurashiki T; Kitagawa Y; Hanaki T; Sakamoto T; Honjo S; Umekita Y; Fujiwara Y; Matsura T
Cancer Lett; 2020 Feb; 470():149-160. PubMed ID: 31765735
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity.
Taniuchi K; Furihata M; Hanazaki K; Iwasaki S; Tanaka K; Shimizu T; Saito M; Saibara T
Pancreas; 2015 Mar; 44(2):331-40. PubMed ID: 25426613
[TBL] [Abstract][Full Text] [Related]
16. Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.
Ryu YK; Lee YS; Lee GH; Song KS; Kim YS; Moon EY
Int J Cancer; 2012 Nov; 131(9):2067-77. PubMed ID: 22328534
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
18. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
[TBL] [Abstract][Full Text] [Related]
19. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
[TBL] [Abstract][Full Text] [Related]
20. Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts.
Goicoechea SM; García-Mata R; Staub J; Valdivia A; Sharek L; McCulloch CG; Hwang RF; Urrutia R; Yeh JJ; Kim HJ; Otey CA
Oncogene; 2014 Mar; 33(10):1265-73. PubMed ID: 23524582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
